Fiscal Year 2017
Released February, 2016
Changes in Performance Measures
| OPDIV | UNIQUE IDENTIFIER | CHANGE TYPE | ORIGINAL MEASURE IN FY 2015 REPORT Released 3/2014 | PROPOSED MEASURE CHANGE | REASON FOR CHANGE |
|---|---|---|---|---|---|
| ACF | 3D (Head Start) |
Add | N/A | Add the following new outcome measure: “Increase the percentage of Head Start and Early Head Start teachers that have a Bachelor’s Degree (BA) or higher.” | This new outcome measure supports the FY 2016-17 Priority Performance Goal on Early Childhood Education to track progress on increasing the credentials of both Head Start and Early Head Start teachers. This measure is distinct from outcome measure 3C in that it looks at credentialing for both Head Start and Early Head Start, rather than focusing on solely the Head Start teachers. |
| ACF | 7S (Foster Care) |
Target Change | FY 2016 Target: 4.7% | Revise FY 2016 Target to 5.1%. | In light of the most recent (FY 2014) actual result, which shows an increase, ACF proposed reducing the FY 2016 target in the Annual Financial Report, which OMB has approved. |
| AHRQ | 1.3.39 | Retire | Increase the number of patient safety events (e.g. medical errors) reported to the Network of Patient Safety Databases (NPSD) from baseline. | Retire measure at the end of FY 2015. | Program requests retirement of the measure, as it is no longer meaningful. Submission to the NPSD is voluntary, and in the past years none of the data transmitted to the PSO PPC have been of sufficient quality and volume. This performance measure is no longer meaningful to report as a GPRA measure and will be retired at the end of FY 2015. |
| ASA | 1.1 | Retire | Increase the percent employees on telework or on Alternative Work Schedule | Retire | Goal is difficult to measure and subject to reporting error given current reporting mechanisms. |
| ASA | 2.8 | New | Increase hiring speed; i.e., the percentage of hires made within 80 day | New, FY17 increase to 44%, end-to-end hiring actions completed in 80 days | OMB request |
| ASA | 3.1 | New | Unprivileged Users 2 Factor Authentication | New, HHS will increase two-factor authentication (LOA-4) for unprivileged users to 92% in FY2017 | ASFR request |
| ASA | 3.2 | New | Privileged Users 2-Factor Authentication | New, HHS will increase two-factor authentication (LOA-4) for privileged users to 98% in FY2017 | ASFR request |
| ASPR | 2.4.13 | Correcting error | Targets for Chemical, Biological, Radiological, and Nuclear countermeasures: Licensed= 2 new; Emergency Use Authority = 5 new. Targets for Pandemic Influenza or Emerging Infectious Disease: Licensed=+2; Emergency Use Authority= +3. | Targets for Chemical, Biological, Radiological, and Nuclear countermeasures: Licensed= 2 new; EUA = 1 new. Targets for Pandemic Influenza or Emerging Infectious Disease: Licensed=1 new EUA = 0. |
Originally was input into PPTS with an error. It erroneously stated targets as "new" when those numbers were actually cumulative numbers. New wording states the actual new product numbers. |
| CDC | 3.3.2a | Retire and replace | Reduce the incidence (per 100,000 population) of healthcare associated invasive MRSA infections (per 100,000 person) | Replace with 3.3.2b: Reduce invasive* healthcare-associated Methicillin-resistant Staphylococcus aureus (MRSA infections) *All invasive infections manifesting as bacteremia |
This measure is being revised to provide more useful data, depicting a more accurate and focused national estimated rate of healthcare associated MRSA bacteremia infections, which is the most common type of invasive MRSA infection. The revised measure will incorporate National Healthcare Safety Network (NHSN) data into the reporting and is consistent with the measures and targets that have been put forth in the HHS Action Plan to Prevent Healthcare-Associated Infections (HAIs). |
| CDC | 3.3.2b | New | Reduce invasive* healthcare-associated Methicillin-resistant Staphylococcus aureus (MRSA infections) *All invasive infections manifesting as bacteremia Replaces 3.3.2a |
This measure is being revised to provide more useful data, depicting a more accurate and focused national estimated rate of healthcare associated MRSA bacteremia infections, which is the most common type of invasive MRSA infection. The revised measure will incorporate National Healthcare Safety Network (NHSN) data into the reporting and is consistent with the measures and targets that have been put forth in the HHS Action Plan to Prevent Healthcare-Associated Infections (HAIs) | |
| CDC | 3.2.5 | New | Increase the percentage of hospitals reporting implementation of antibiotic stewardship programs fully compliant with CDC Core Elements for Hospital Antibiotic Stewardship Programs (Outcome, HHS Agency Priority Goal) | This is the FY 2016-2017 Agency Priority Goal | |
| CMS | CHIP3: Improve availability and accessibility of health insurance coverage by increasing enrollment of eligible children in the Children's Health Insurance Program (CHIP) and Medicaid | Revise 2016 target. | 48,667,385 children (CHIP 8,909,064/ Medicaid 39,758,322) |
45,271,662 children (CHIP – 9,054,332/ Medicaid – 36,217,330) |
CMS has invested considerable effort in improving the quality of the data reported by states in the last two years, which has uncovered a number of systems-related challenges that have resulted in both increases and decreases in reported enrollment. Some of the issues have included duplication of enrollment counts between Medicaid and CHIP and incorrect reporting of children in Medicaid Expansion CHIP Programs. Based on these factors, the FY 2016 target has been reduced to reflect revised data . |
| CMS | CMMI2: Identify, test, and improve payment and service delivery models: | Revise measure title for CMMI2.1 | CMMI2.1 Increase the number of model tests that demonstrate : 1) cost savings while maintaining or improving quality, and/or 2) improving quality while maintaining or reducing cost. | CMMI2.1 Increase the number of model tests that currently indicate : 1) cost savings while maintaining or improving quality, and/or 2) improving quality while maintaining or reducing cost. | This measure has been reworded re-worded for the sake of consistence consistency with the other measures included in this goal. |
| CMS | MCR26 Reduce All-Cause Hospital Readmissions Rates | Revise 2016 target. | 17.7% | 17.4% | Target was adjusted downward to be more aggressive. |
| CMS | MIP9 Estimate the Improper Payment Rate in the Medicaid and Children's Health Insurance Programs | Goal title change. | Estimate the Payment Error Rate in the Medicaid and Children's Health Insurance Programs | Estimate the Improper Payment Rate in the Medicaid and Children's Health Insurance Programs | CMS wants to be consistent across the board by stating "improper payment rate" for all improper payment rate measurement programs. |
| CMS | MCR30:Shift Medicare health care payments from volume to value | Revised measure title | MCR30 Delivery System Reform: Provide Better Care at Lower Cost across the Health Care System by Improving the Way Providers are Incentivized | MCR30: Shift Medicare health care payments from volume to value | MCR30 is a proposed Agency priority goal. The measure title has been changed to more accurately reflect the outcomes CMS hopes to achieve through this initiative. |
| CMS | MCR30: Health Care Payment Reform: Setting clear goals and timeline for shifting health care reimbursements from volume to value | Discontinued measure 30.2 | MCR30.2 Increase the Percentage of Medicare FFS Payments Linked to Quality and Value | Discontinue | CMS will focus efforts on measure MCR30.1 Increase the Percentage of Medicare FFS Payments Tied to Quality and Value through Alternative Payment Models. |
| FDA | 212409 | Drop | Reducing foodborne illness in the population. By December 31, 2015, decrease the rate of Salmonella Enteritidis (SE) illness in the population from 2.6 cases per 100,000 (2007-2009 baseline) to 1.9 cases per 100,000. | NA | Previous SE Annual Priority Goal (APG) was completed in 2015. |
| FDA | 212410 | New | NA | Reducing foodborne illness in the population. By December 31, 2017, working with federal, state, local, tribal, and industry partners, improve preventive controls in food production facilities and reduce the incidence rate (reported cases per 100,000 population per year) of Listeria monocytogenes (Lm) infections by 8%. | New Listeria Annual Priority Goal (APG). |
| FDA | 293206 | Revised | Promote innovation and predictability in the development of safe and effective nanotechnology- based products by establishing scientific standards and evaluation frameworks to guide nanotechnology-related regulatory decisions. Target: 30 CORES projects completed |
Promote innovation and predictability in the development of safe and effective nanotechnology- based products by establishing scientific standards and evaluation frameworks to guide nanotechnology-related regulatory decisions.
Target: 30 CORES projects with completed annual milestones |
Target wording was revised to reflect the fact that some of these projects are multi-year, although the expected annual milestones have all been met. |
| HRSA | 4.I.C.2 NHSC |
FY 2016 target change |
Field Strength of the NHSC through scholarships and loan repayment agreements | FY 2016 target change |
The targets for the NHSC are directly related to the NHSC budget. |
| HRSA | 29.IV.A.3. ORHP |
Revise Wording | Increase the number of people receiving direct services through Outreach grants | The number of unique individuals who receive direct services through ORHP Outreach grants | Wording changed to indicate that individuals are counted only once in this measure. |
| IHS | 18 | Revise Measure Name | Proportion of adults ages 18 and over who are screened for depression | Proportion of American Indian and Alaska Native adults 18 and over who are screened for depression | Specify that the screening population is American Indian and Alaska Native, not the U.S. adult population |
| IHS | 20 | Revise measure type | 100 percent of hospitals and outpatient clinics operated by the Indian Health Service are accredited or certified (excluding tribal and urban facilities) | Change the performance measure type from Annual Performance Plan measure to budget measure beginning in 2017 | Requested by HHS. |
| IHS | 24 | Revise name after 2016 | American Indian and Alaska Native patients, aged 19-35 months, receive the following childhood immunizations: 4 DTaP (diphtheria, tetanus, and acellular pertussis); 3 IPV (polio); 1 MMR (measles, mumps, rubella); 3 or 4 Hib (Haemophilus influenza type b); 3 HepB (hepatitis B); 1 Varicella (chicken pox); 4 Pneumococcal conjugate | Revise measure title American Indian and Alaska Native Childhood Combined (4:3:1:3*:3:1:4) immunization rates: American Indian/Alaska Native patients aged 19 -35 months, are immunized against preventable childhood diseases. | Replace budget measure with a different title in 2017 label all vaccines included. |
| IHS | 30 | Revise FY 2016 measure and retire after 2016 report year | American Indian and Alaska Native patients, 22 and older, with Coronary Heart Disease are assessed for five cardiovascular disease (CVD) risk factors | Remove the following numerator from the measure: "Patients with LDL completed during the report period, regardless of result." Replace measure with ID 51 in 2017. | The new ACC/AHA cholesterol guidelines no longer recommend treating to LDL targets. Instead, they recommend statin medication therapy. For 2016, IHS would report on a composite result of the 4 remaining numerators of the CVD Comprehensive Assessment representative set measure. |
| IHS | 51 | New Indicator in CRS for 2017 to replace ID 30 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease among American Indians and Alaska Natives | Measure will focus on statin medication therapy. | IHS will develop a new CVD measure based upon the new ACC/AHA standards of care to replace the current measure 30: Comprehensive CVD-related Assessment. |
| IOS | 1.7 | New Measure for FY16 | N/A | N/A | New measure to document the number of innovative acquisitions for IT services throughout the Department in collaboration with the HHS IDEA Lab |
| NIH | SRO-5.13 | Retire (Measure will discontinue in FY 2016) | By 2015, establish and evaluate a process to prioritize compounds that have not yet been adequately tested for more in-depth toxicological evaluation. | N/A | Measure was achieved in FY 2015. |
| NIH | SRO-6.4 | Retire (Measure will discontinue in FY 2016) | By 2015, identify and characterize two molecular pathways of potential clinical significance that may serve as the basis for discovering new medications for preventing and treating asthma exacerbations. | N/A | Measure was achieved in FY 2015. |
| NIH | CBRR-10 | Retire (Measure will discontinue in FY 2016) | By 2015, make freely available to researchers the results of 400 high-throughput biological assays screened against a library of 300,000 unique compounds, and the detailed information on the molecular probes that are developed through that screening process. | N/A | Measure was achieved in FY 2015. |
| NIH | SRO-8.2 | Retire (Measure will discontinue in FY 2018) | By 2017, identify circuits within the brain that mediate reward for 1) drugs, 2) non-drug rewards such as food or palatable substances, and 3) aversion to drug effects, and 4) determine the degree of overlap between these circuits. | N/A | Measure is expected to be achieved in FY 2017. |
| SAMHSA | 3.2.02a | Target Changes | Increase the percentage of children receiving trauma informed services who report positive functioning at 6 month follow-up (Outcome) | FY17 and FY18 targets were increased to 77%. | SAMHSA establishes ambitious targets. This change aligns the targets with recent actual results. |
